Assessments

Economics of Neuroscience

Volumn 4, Issue 2, 2002, Pages 25-

  Markowitz, John C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

DEPRESSION; DRUG SAFETY; EDITORIAL; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MANAGED CARE ORGANIZATION; MEDICAL RESEARCH; OUTCOMES RESEARCH; PATIENT EDUCATION; PRACTICE GUIDELINE; PSYCHODYNAMICS; PSYCHOTHERAPY; RECURRENCE RISK; REIMBURSEMENT; STANDARDIZATION; SUICIDAL BEHAVIOR; SYMPTOMATOLOGY; VALIDATION PROCESS;

EID: 0036487353     PISSN: 15270815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry. 1998;55:694-700.
2. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;25:56-62
3. Markowitz JC. Interpersonal Psychotherapy for Dysthymic Disorder. Washington, DC; American Psychiatric Press, 1998.
4. Goldman W, McCulloch J, Cuffel B, Zarin DA, Suarez A, Burns BK. Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. Psych Serv. 1998;49:477-482.
5. American Psychiatric Association: Handbook of Psychiatric Measures. Rush AJ, Pincus HA, Fist MB, et al, eds. Washington, DC: American Psychiatric Association, 2000.